Assessing the Future of Solid Tumor Immunotherapy.

Guha, Prajna; Heatherton, Kara R; O'Connell, Kyle P; Alexander, Ian S; Katz, Steven C

Guha, Prajna; Heatherton, Kara R; O'Connell, Kyle P; Alexander, Ian S; Katz, Steven C.

Afiliación

Guha P; Roger Williams Medical Center, Immuno-Oncology Institute, Providence, RI 02908, USA.
Heatherton KR; Department of Surgery, Boston University Medical Center, Boston, MA 02118, USA.
O'Connell KP; Roger Williams Medical Center, Immuno-Oncology Institute, Providence, RI 02908, USA.
Alexander IS; Roger Williams Medical Center, Immuno-Oncology Institute, Providence, RI 02908, USA.
Katz SC; Roger Williams Medical Center, Immuno-Oncology Institute, Providence, RI 02908, USA.

Biomedicines ; 10(3)2022 Mar 11.

Article en En | MEDLINE | ID: mdl-35327456

Palabras clave

CAR-NK; CAR-T; On-target-off-tumor-toxicity; adoptive cell therapy; cytokine release syndrome; immune checkpoint inhibitors; myeloid derived suppressor cells; single chain variable fragment (scFv); tumor microenvironment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Aspecto: Patient_preference Idioma: En Revista: Biomedicines Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google